Related Experiment Video
Updated: Jun 2, 2025

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025
Douglas E Wood1, Ella A Kazerooni2, Denise R Aberle3
1Fred Hutchinson Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|January 17, 2025
Summary
The National Comprehensive Cancer Network (NCCN) Guidelines offer updated recommendations for lung cancer screening, including criteria for selecting eligible individuals and managing detected lung nodules. These insights highlight recent revisions to the established lung cancer screening protocols.
Area of Science:
- Oncology
- Pulmonology
- Radiology
Background:
- Lung cancer remains a leading cause of cancer-related mortality worldwide.
- Early detection through screening can significantly improve patient outcomes.
- The National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer care.
Purpose of the Study:
- To summarize recent updates to the NCCN Clinical Practice Guidelines for Lung Cancer Screening.
- To highlight key changes in criteria for screening eligibility.
- To outline updated recommendations for lung nodule evaluation and management.
Main Methods:
- Review of the latest NCCN Guidelines for Lung Cancer Screening.
- Analysis of specific updates concerning screening eligibility criteria.
- Examination of revised protocols for lung nodule characterization and follow-up.
Main Results:
- The NCCN Guidelines have been updated to refine criteria for selecting individuals for lung cancer screening.
- New recommendations address the evaluation and management of lung nodules identified during screening.
- These updates aim to optimize the effectiveness and safety of lung cancer screening programs.
Conclusions:
- Adherence to the updated NCCN Guidelines is crucial for effective lung cancer screening.
- The revisions aim to improve early detection rates and patient management for lung cancer.
- These guideline updates support standardized and evidence-based approaches to lung cancer screening and nodule management.
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
82
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
82
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Standards of Care II
635
Nurses bear specific legal responsibilities under several federal statutes, including:
635

